Loading

Hope in motion: Monitoring drug efficacy for neurodegenerative diseases

Hope in motion: Monitoring drug efficacy for neurodegenerative diseases

Neurodegenerative diseases affect millions worldwide. Fifty million people are living with Alzheimer's disease or other dementias. Although Alzheimer's disease is one of the most recognized, it is just one of many neurological disorders, such as…

Read More
ICH M10 Guidelines as the Gold Standard
  • March 1, 2023
  • News

ICH M10 Guidelines as the Gold Standard

Setting the Bar for Scientific Consistency: The ICH M10 Guideline as the Gold Standard! ICH M10 (International Committee of Harmonization Multidisciplinary guideline) provides guidance on bioanalytical method validation and study sample analysis for the measurement…

Read More
Antibody Industrial Symposium (AIS) – Booth #1
  • June 22-23, 2023
  • Tours, France
  • Events

Antibody Industrial Symposium (AIS) – Booth #1

We are excited to announce we will be exhibiting at the 11th Antibody Industrial Symposium 2023 (AIS2023) that will be held from 22nd to 23rd June 2023 in person in Tours, France. This international congress…

Read More
AD/PD 2023 – Booth #48
  • March 28th - April 1st, 2023
  • Gothenburg, Sweden
  • Events

AD/PD 2023 – Booth #48

Join our team at the International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders at booth #48. This premier gathering of experts from around the world will take place in the vibrant city…

Read More
Creating a Roadmap for Your Functional Assays
  • January 26, 2023
  • News

Creating a Roadmap for Your Functional Assays

With Functional Assays, you often know where you want to be but not always how to get there… Active Biomarkers can help. by Christine Bain, PhD Understanding the interactions between drugs and biological systems is…

Read More

KCAS and Active Biomarkers join forces

KCAS Bioanalytical and Biomarker Services (KCAS), a leading bioanalytical contract research organization (CRO), backed by Vitruvian Partners, closed the purchase of Active Biomarkers, located in Lyon, France. Active Biomarkers is a renowned assay development and…

Read More